. France, Unité de Recherche Clinique. 11 Service de Dermatologie, Centre Léon Bérard, 12 Réseau NF-Rhône-Alpin

S. Rasmussen, Q. Yang, and J. Friedman, Mortality in Neurofibromatosis 1: An Analysis Using U.S. Death Certificates, The American Journal of Human Genetics, vol.68, issue.5, pp.1110-1118, 2001.
DOI : 10.1086/320121

V. Riccardi, Neurofibromatosis, Plastic and Reconstructive Surgery, vol.91, issue.3, 1992.
DOI : 10.1097/00006534-199303000-00029
URL : https://hal.archives-ouvertes.fr/inserm-00748122

J. Woodruff, Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis, American Journal of Medical Genetics, vol.18, issue.1, pp.23-30, 1999.
DOI : 10.1002/(SICI)1096-8628(19990326)89:1<23::AID-AJMG6>3.0.CO;2-#

K. Khosrotehrani, S. Bastuji-garin, J. Zeller, J. Revuz, and P. Wolkenstein, Clinical Risk Factors for Mortality in Patients With Neurofibromatosis 1, Archives of Dermatology, vol.139, issue.2, pp.187-91, 2003.
DOI : 10.1001/archderm.139.2.187

K. Khosrotehrani, S. Bastuji-garin, V. Riccardi, P. Birch, J. Friedman et al., Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: A cohort study of 703 patients, American Journal of Medical Genetics Part A, vol.79, issue.1, pp.49-53, 2005.
DOI : 10.1002/ajmg.a.30394

E. Sbidian, P. Wolkenstein, L. Valeyrie-allanore, D. Rodriguez, S. Hadj-rabia et al., NF-1Score: A Prediction Score for Internal Neurofibromas in Neurofibromatosis-1, Journal of Investigative Dermatology, vol.130, issue.9, pp.2173-2181, 2010.
DOI : 10.1038/jid.2010.100

A. Drouet, P. Wolkenstein, J. Lefaucheur, S. Pinson, P. Combemale et al., Neurofibromatosis 1-associated neuropathies: a reappraisal, Brain, vol.127, issue.9, pp.1993-2009, 2004.
DOI : 10.1093/brain/awh234

. Neurofibromatosis, Conference statement. National Institutes of Health Consensus Development Conference, Arch Neurol, vol.45, issue.5, pp.575-583, 1988.

S. Rasmussen and J. Friedman, NF1 Gene and Neurofibromatosis 1, American Journal of Epidemiology, vol.151, issue.1, pp.33-40, 2000.
DOI : 10.1093/oxfordjournals.aje.a010118

L. Valeyrie-allanore, N. Ismaili, S. Bastuji-garin, J. Zeller, J. Wechsler et al., Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1, British Journal of Dermatology, vol.12, issue.1, pp.79-82, 2005.
DOI : 10.1038/ng0293-122

S. Pinson, A. Creange, S. Barbarot, J. Stalder, Y. Chaix et al., Neurofibromatosis 1: recommendations for management, Ann Dermatol Venereol, vol.128, issue.4, pp.567-75, 2001.

J. Friedman and P. Birch, Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients, American Journal of Medical Genetics, vol.131, issue.2, pp.138-181, 1997.
DOI : 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U

E. Pasmant, P. Lévy, I. Laurendeau, N. Ortonne, B. Parfait et al., Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients, Mol Med, vol.17, pp.79-87, 2011.